ETS2 targets ZMYND11 to inhibit thyroid cancer progression via the mTOR signaling pathway - Taipengfei Shu; Xinhua Wu; Chengqun Wei; Chaofeng Chen; Chao Shen; Yujie Huang; Jie Zhou; Liangxing Jiang; Ting Yan; Wen Shi; Liming Ma; Yan Yan; et al. (PLoS ONE, 2025)